Glisoxepide - CISMeF

Preferred Label : Glisoxepide;

NCIt definition : A second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, glisoxepide exerts greater binding affinity than the first-generation compounds. Glisoxepide shows peroxisome proliferator-activated receptor (PPAR) gamma agonistic activity, has a short half-life and is excreted in both the bile and urine.;

UNII : H7SC0I332I;

InChIKey : ZKUDBRCEOBOWLF-UHFFFAOYSA-N;

CAS number : 25046-79-1;

Chemical formula : C20H27N5O5S;

Details

Origin ID

C72801;

UMLS CUI

C0061330;

Automatic exact mappings (from CISMeF team)
- Glisoxepide [ICHI extension code]
Currated CISMeF NLP mapping
- Glisoxepide [ICD-11 Extension code]
- glisoxepide [Substance BNPC]
- glisoxepide [MeSH concept]
- glisoxepide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Glisoxepide [ICD-11 Extension code]
- glisoxepide [ATC Code]
- glisoxepide [Substance BNPC]
- glisoxepide [MeSH concept]
- glisoxepide [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- glisoxepide [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients